leisure time -WSS

leisure time

author：leisure time 2025-09-05 13:46:07 - browse：963

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： 'Reaching a detente': STAT's Helen Branswell on covering Covid

focus

WSS

Couple fighting to bring baby home from Mexico are finally reunited

Researchers separate signal from noise in heart wearable data

Medical experts are missing from AI regulatory conversations

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Why the Crimean Bridge is key to Russia's war in Ukraine

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Norman Reedus' Daryl Dixon

Walensky prepares to leave CDC — and Congress — behind

Why the Crimean Bridge is key to Russia's war in Ukraine

Medical leaders decry Supreme Court decision on affirmative action

Resistance to cancer drugs: A new genetic explanation

Duchenne breakthrough therapy leaves behind pioneering families

The kidney, in all its complexity, is captured in a new atlas

Virginia high school admissions case could be legal follow

The kidney, in all its complexity, is captured in a new atlas

focus

'Reaching a detente': STAT's Helen Branswell on covering Covid

Trump got a 'target letter.' What is one and what does it mean?

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

How dance can help health care workers heal from trauma

explore

focus

Wikipedia

explore